These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series. Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115 [TBL] [Abstract][Full Text] [Related]
11. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode. Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides. Stokes SS; Albert R; Buurman ET; Andrews B; Shapiro AB; Green OM; McKenzie AR; Otterbein LR Bioorg Med Chem Lett; 2012 Dec; 22(23):7019-23. PubMed ID: 23099094 [TBL] [Abstract][Full Text] [Related]
13. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation. Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086 [TBL] [Abstract][Full Text] [Related]
14. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase. Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU. Li Y; Zhou Y; Ma Y; Li X Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310 [TBL] [Abstract][Full Text] [Related]
16. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis. Mengin-Lecreulx D; van Heijenoort J J Bacteriol; 1994 Sep; 176(18):5788-95. PubMed ID: 8083170 [TBL] [Abstract][Full Text] [Related]
17. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery. Sharma R; Khan IA Curr Drug Targets; 2017; 18(14):1587-1597. PubMed ID: 27138757 [TBL] [Abstract][Full Text] [Related]
18. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer. Jagtap PK; Soni V; Vithani N; Jhingan GD; Bais VS; Nandicoori VK; Prakash B J Biol Chem; 2012 Nov; 287(47):39524-37. PubMed ID: 22969087 [TBL] [Abstract][Full Text] [Related]
19. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on Chen C; Han X; Yan Q; Wang C; Jia L; Taj A; Zhao L; Ma Y Front Cell Infect Microbiol; 2019; 9():251. PubMed ID: 31380295 [No Abstract] [Full Text] [Related]
20. Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli. Gehring AM; Lees WJ; Mindiola DJ; Walsh CT; Brown ED Biochemistry; 1996 Jan; 35(2):579-85. PubMed ID: 8555230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]